Search Results - "Mehrhof, F"

In cardiomyocyte hypoxia, insulin-like growth factor-I-induced antiapoptotic signaling requires phosphatidylinositol-3-OH-kinase-dependent and mitogen-activated protein kinase-dependent activation of the transcription factor cAMP response element-binding protein by MEHRHOF, Felix B, MÜLLER, Frank-Ulrich, BERGMANN, Martin W, PEIFENG LI, YIBIN WANG, SCHMITZ, Wilhelm, DIETZ, Rainer, VON HARSDORF, Rüdiger

“…A variety of pathologic stimuli lead to apoptosis of cardiomyocytes. Survival factors like insulin-like growth factor-I (IGF-I) exert anti-apoptotic effects in…”
Get full text

A step towards routine for stereotactic radioablation in refractory ventricular tachycardia – interim analysis on short term safety of the first prospective, multi-centre, multi-platform study RAVENTA by Zaman, A, Krug, D, Eidinger, L, Boda-Heggemann, J, Rudic, B, Mehrhof, F, Boldt, L H, Fleckenstein, J, Kluge, A, Siebert, F A, Schweikard, A, Vontlein, R, Dunst, J, Bonnemeier, H, Blanck, O

“…Abstract Background Ventricular tachycardia (VT) is a potentially life-threatening heart rhythm disorder originating in heterogeneous conduction velocity in…”
Get full text

Stereotactic Arrhythmia Radioablation (STAR) for refractory ventricular tachycardia (VT) - A preliminary report from the German multicenter RAVENTA study by Krug, D, Hohmann, S, Boda-Heggemann, J, Mehrhof, F, Grehn, M, Lyan, E, Merten, R, Rudic, B, Boldt, L H, Kirstein, B, Rades, D, Bonnemeier, H, Dunst, J, Tilz, R, Blanck, O

“…Abstract Funding Acknowledgements Type of funding sources: Public grant(s) – EU funding. Main funding source(s): The multicenter RAdiosurgery for VENtricular…”
Get full text

Reproducible target transfer from electroanatomic mapping to radiotherapy planning systems for cardiac radioablation - cross-validation for the RAVENTA trial by Hohmann, S, Xie, J, Grehn, M, Karfoul, N, Mehrhof, F, Merten, R, Rudic, B, Krug, D, Lyan, E, Duncker, D, Dunst, J, Tilz, R, Schweikard, A, Blanck, O, Boda-Heggemann, J

“…Abstract Funding Acknowledgements Type of funding sources: Public grant(s) – EU funding. Main funding source(s): RAVENTA is part of the EU-Horizon-2020…”
Get full text

PV-0256 European survey on electronic patientreported outcomes by the EORTC young Radiation Oncology Group by Thieme, A.H., Eller, Y.G., del Campo, E. Rivin, Abrunhosa-Branquinho, A., Adebahr, S., Desideri, I., Fiore, M., Hafeez, S., Hoeben, B., Kaidar-Person, O., Kindts, I., Meattini, I., Mercier, C., Mehrhof, F., Nevens, D., Ollivier, L., Suppli, M.H., Visani, L., Baumert, B.G., Ostheimer, C.

Get full text

Résultats français d’une enquête internationale sur les « patient-reported outcomes » électroniques réalisée par le Young Radiation Oncology Group de l’European Organization for the Research and Treatment of Cancer by Rivin Del Campo, E., Ollivier, L., Clementel, E., Suppli, M.H., Adebahr, S., Branquinho, A., Hafeez, S., Kaidar-Person, O., Nevens, D., Meattini, I., Ciervide, R., Desideri, I., Eller, Y., Hoeben, B., Kindts, I., Mehrhof, F., Mercier, C., Ostheimer, C., Visani, L., Zhu, H., Thieme, A.

“…Les effets secondaires liés à la radiothérapie sont habituellement rapportés par les médecins à la place des patients. Les patient-reported outcomes (PROs)…”
Get full text

E2F-1 overexpression in cardiomyocytes induces downregulation of p21(CIP1) and p27(KIP1) and release of active cyclin-dependent kinases in the presence of insulin-like growth factor I by Rudiger von Harsdorf, Hauck, Ludger, Mehrhof, Felix, Wegenka, Ursula

“…The heart is a postmitotic organ unable to regenerate after injury. The mechanisms controlling cell cycle arrest in cardiomyocytes are still unknown…”
Get full text

Ventricular tachycardia as the first manifestation of cardiac sarcoidosis by Mehrhof, Felix, Stockburger, Martin, Schuette, Hartwig, Haverkamp, Wilhelm, Dietz, Rainer

“…The case of a 32-year-old man with sustained ventricular tachycardia and hypotension is described. Following pharmacological treatment the patient switched to…”
Get full text

E2F-1 Overexpression in Cardiomyocytes Induces Downregulation of p21CIP1 and p27KIP1 and Release of Active Cyclin-Dependent Kinases in the Presence of Insulin-Like Growth Factor I by von Harsdorf, Rüdiger, Hauck, Ludger, Mehrhof, Felix, Wegenka, Ursula, Cardoso, M Cristina, Dietz, Rainer

“…The heart is a postmitotic organ unable to regenerate after injury. The mechanisms controlling cell cycle arrest in cardiomyocytes are still unknown…”
Get full text